surpass cvot tirzepatide results In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Can Dual Incretin Receptor Agonists

"When the medical system doesn't know exactly what the best recommendation is people are smart

As major vendors exit the tirzepatide market, the remaining supply becomes concentrated among smaller, potentially less reliable sources

Practical Strategies to Reduce Nausea While Taking Semaglutide Eating smaller, more frequent meals prevents overwhelming a stomach that is already emptying more slowly

A steep price cut might limit future sales growth (the first round of price negotiation last year saw a 38% to 79% price reduction across the selected drugs), though we still expect [Novo] to remain one of the market leaders in the obesity market, Nurhayati wrote in a note Monday